Vimian’s MedTech segment Movora has today acquired IMEX, a family-owned supplier of orthopedic implants for the veterinary market. The company was founded by Doctor of Veterinary Medicine Hall Griffin in 1990 and is based in Texas, USA. Today, IMEX has 17 employees and is a market leader within the niche of external fixation.
“Through the acquisition of IMEX we enter a new niche segment within surgical products and complement our existing product portfolio in Movora. IMEX has a strong reputation in the veterinary market with its high-quality product brands and long-term stakeholder relationships. I have known Dr Hall Griffin for 30 years and I am excited to now work together with him and his team”, says Chris Sidebotham, co-CEO of Vimian’s MedTech segment Movora.
The acquisition will have a marginal impact on Vimian Group’s earnings per share. The acquisition is financed with available funds as well as an issue in kind, resolved by the Board of Vimian based on the authorization granted by the Annual General Meeting of 2021, of a total of 110,940 shares, comprising of 55,470 ordinary shares and 55,470 class C shares, to Dr Hall Griffin as a reinvestment in Vimian Group.
The total number of shares in Vimian Group following the acquisition will amount to 389,321,230 of which 364,445,155 ordinary shares and 24,876,075 class C shares.
IMEX was consolidated into Vimian Group’s MedTech segment on 21 December 2021.
